IV Medication for Acute Severe Anxiety
For acute severe anxiety in an emergency or critical care setting, IV lorazepam is the preferred benzodiazepine, with a typical starting dose of 0.02-0.04 mg/kg (≤2 mg) administered slowly over several minutes, followed by maintenance dosing of 0.02-0.06 mg/kg every 2-6 hours as needed. 1, 2
Primary Recommendation: Lorazepam
Lorazepam is preferred over other benzodiazepines when IV access is available because it offers several clinical advantages 1:
- Longer duration of action (1-24 hours) compared to midazolam (1-4 hours), providing more sustained anxiety control 2
- More predictable pharmacokinetics with stable elimination and no active metabolites that accumulate 1, 3
- Onset within 15-20 minutes after IV administration, though slower than midazolam 1
Dosing Protocol for Lorazepam
- Loading dose: 0.02-0.04 mg/kg IV (maximum 2 mg per dose) administered over several minutes
- Maintenance: 0.02-0.06 mg/kg every 2-6 hours as needed, or continuous infusion at 0.01-0.1 mg/kg/hr (≤10 mg/hr)
Critical dose adjustments 2:
- Elderly patients: Reduce dose by 20% or more due to decreased clearance
- Respiratory disease/COPD: Use lower doses due to increased risk of respiratory depression
- When combined with opioids or other CNS depressants: Reduce initial doses of both agents
Alternative Option: Midazolam
Midazolam may be considered when rapid onset is essential (onset 2-5 minutes vs. 15-20 minutes for lorazepam) 1, 4:
- Loading dose: 0.01-0.05 mg/kg IV over several minutes 1
- Maintenance: 0.02-0.1 mg/kg/hr continuous infusion 1
- Shorter duration of action requires continuous infusion for sustained effect 1, 3
Midazolam is particularly useful 4, 3:
- When immediate sedation/anxiolysis is needed before procedures
- In ICU settings where continuous infusion is already established
- When shorter duration allows for more rapid titration
Critical Safety Monitoring
Mandatory monitoring during IV benzodiazepine administration 2:
- Oxygen saturation and respiratory effort must be continuously monitored
- Be prepared to support ventilation, as rapid IV administration or combination with opioids significantly increases apnea risk
- Respiratory depression is most likely in patients with underlying respiratory disease or when combined with other CNS depressants 2
Important Clinical Pitfalls to Avoid
Common errors that worsen outcomes 2, 5:
- Paradoxical agitation: Benzodiazepines alone may paradoxically worsen agitation or cause delirium, particularly in elderly patients
- Combining with high-dose antipsychotics: Lorazepam combined with high-dose olanzapine has fatality reports
- Rapid IV push: Always administer over 2-3 minutes minimum to reduce apnea risk 4
- Inadequate dose reduction in elderly: Failure to reduce doses by ≥20% in older adults increases adverse events 2
When Benzodiazepines Are NOT First-Line
For delirium-related agitation, benzodiazepines should NOT be used as monotherapy 5:
- Antipsychotics (olanzapine 2.5-5 mg or haloperidol 0.5-1 mg) are preferred first-line agents
- Benzodiazepines may be added only for severe agitation refractory to antipsychotics
- If added, use lorazepam 0.25-0.5 mg with extreme caution in elderly patients 5
Practical Algorithm for Drug Selection
Choose lorazepam when 1, 2, 3:
- Sustained anxiolysis is needed (>4 hours)
- Patient has renal impairment (no active metabolites)
- Cost is a consideration (lower acquisition cost)
- Hemodynamic stability allows for 15-20 minute onset
Choose midazolam when 1, 4, 3:
- Immediate onset is critical (<5 minutes needed)
- Procedure-related anxiety requiring brief sedation
- Continuous infusion already established in ICU
- Rapid titration and offset desired
Avoid diazepam due to active metabolites that prolong sedation, especially in renal failure, and high risk of phlebitis with peripheral IV administration 1